Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulinastatin for perioperative organ protection in children with complex congenital heart disease undergoing cardiopulmonary bypass
ChiCTR-TRC-14005219Phase 4Not yet recruiting
- Sponsor
- Shanghai Children's Medical Center
- Start
- Sep 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ulinastatin in Cardiovascular Malformation (CVM) (2 arms), sponsored by Shanghai Children's Medical Center. Primary endpoint: Dynamic change in PaO2/FiO2 ratio. Planned start Sep 2014; status: not yet recruiting.
02
Drugs
ulinastatin
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on ChiCTR-TRC-14005219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14005219.